剖宫产出院后非阿片类与阿片类镇痛的随机等效性试验
该随机等效性试验将170例剖宫产产妇分为出院后布洛芬加对乙酰氨基酚的非阿片类组(n=85)与布洛芬加氢可酮-对乙酰氨基酚的阿片类组(n=85),主要结局为产后2-4周视觉模拟量表疼痛评分,获得149例(88%)数据。两组疼痛评分未达到等效,非阿片类组平均疼痛评分更低(12.3±19.5 vs 15.9±20.4 mm,校正均数差4.8;95%CI -2.1至11.9 mm)。结论认为剖宫产术后2-4周非阿片类镇痛组的疼痛评分更低。
要点
- 剖宫产出院后非阿片类组产后2-4周疼痛评分低于阿片类组。
- 两组疼痛评分差异的95%CI超出预设等效界值(-10至10 mm),未达等效。
- 非阿片类方案为布洛芬加对乙酰氨基酚,阿片类方案为布洛芬加氢可酮-对乙酰氨基酚。
核心结论
- 剖宫产术后2-4周,接受非阿片类镇痛药的产妇疼痛评分低于接受阿片类镇痛药的产妇,两组未达到等效。
研究设计与样本
- 随机等效性试验,纳入170例剖宫产产妇,非阿片类组(布洛芬加对乙酰氨基酚)n=85,阿片类组(布洛芬加氢可酮-对乙酰氨基酚)n=85。
- 主要结局为产后2-4周视觉模拟量表疼痛评分,获得149例(88%)产妇的数据。
- 等效性判定标准为两组平均疼痛评分差值的95%置信区间在-10至10 mm之间。
- 采用零膨胀负二项模型估计组间均数差。
主要发现
- 非阿片类组平均疼痛评分为12.3±19.5 mm,阿片类组为15.9±20.4 mm。
- 校正均数差为4.8(95%CI -2.1至11.9 mm),置信区间超出等效界值,两组未达到等效。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether pain score after cesarean delivery is equivalent among women receiving outpatient nonopioid vs opioid analgesics. STUDY DESIGN: In this trial 170 women with cesarean delivery were randomized to outpatient ibuprofen plus acetaminophen (nonopioid, n=85) or ibuprofen plus hydrocodone-acetaminophen (opioid, n=85). Primary outcome was pain score on a visual analog scale at 2-4 weeks postpartum, which was obtained from 149 (88%) women. Treatments were considered equivalent if the difference between the mean pain scores of each group and its 95% confidence interval were between -10 and 10 mm. A zero-inflated negative binomial model was used to estimate the difference between group means. RESULTS: Treatments were not equivalent; mean pain score was lower (better) in the nonopioid group (12.3±19.5 vs 15.9±20.4 mm, adjusted mean difference, 4.8; 95% CI, -2.1 to 11.9 mm). CONCLUSION: Pain score 2-4 weeks after cesarean delivery was lower in women receiving nonopioid analgesics.
引用
- Dinis J, Soto E, Pedroza C, et al. Nonopioid versus opioid analgesia after hospital discharge following cesarean delivery: a randomized equivalence trial. Am J Obstet Gynecol. 2019. PMID: 31816306. doi:10.1016/j.ajog.2019.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。